Skip to main content
Fig. 6 | Nutrition & Metabolism

Fig. 6

From: Exploring the underlying mechanisms of fisetin in the treatment of hepatic insulin resistance via network pharmacology and in vitro validation

Fig. 6

Effects of fisetin on EGFR and key factors (insulin receptor substrate (IRS) and AKT) in insulin signaling pathway in L02 and HepG2 cells. A Relative expression of RNA and proteins related to fisetin treatment in L02 normal or IR cells. B Relative expression of RNA and proteins related to fisetin treatment in HepG2 normal or IR cells. C Relative expression of RNA and proteins related to EGFR activator (NSC 228155) in L02 IR cells. Control represents untreated L02 cells. * P < 0.05, ** P < 0.01 and *** P < 0.001

Back to article page

Nutrition & Metabolism

ISSN: 1743-7075

Contact us